fbpx
QQQ
+ 2.58
328.93
+ 0.78%
DIA
+ 2.29
343.25
+ 0.66%
SPY
+ 2.93
416.17
+ 0.7%
TLT
-0.69
140.61
-0.49%
GLD
+ 1.55
168.49
+ 0.91%

Why Dynatronics's Stock is Trading Lower Today

February 11, 2021 10:16 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

The Price And Volume Action In Dynatronics's Stock Today

Dynatronics (NASDAQ:DYNT) is currently down 6.05% to a price of $1.34. Thursday the stock has been traded at a volume of 438.61 thousand, about 74.64% of its recent 30-day volume average of 587.62 thousand.

Why It's Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Dynatronics shares are trading lower after the company reported worse-than-expected Q2 EPS and sales results.

Insights On Recent Price Action

The 50-day moving average price of Dynatronics's stock was $0.98 when this article was published. The stock reached a high of $3.7 and a low of $0.52 in the past 52 weeks.

Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.

Posted-In:

Movers Trading Ideas

Related Articles

12 Health Care Stocks Moving In Friday's Pre-Market Session

  read more

48 Stocks Moving In Friday's Mid-Day Session

Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares jumped 52.8% to $5.76. Lixte Biotech recently said it will present its anti-cancer therapy enhancer at HC Wainwright Global Life Sciences Conference being held March 9-10, 2021. read more

33 Stocks Moving in Friday's Pre-Market Session

Gainers Northern Dynasty Minerals Ltd. (NYSE: NAK) rose 85.7% to $1.30 in pre-market trading after the company said the US Army Corps of Engineers has accepted Pebble Limited Partnership's request to initiate an administrative appeal process. read more

70 Biggest Movers From Yesterday

Gainers Pandion Therapeutics, Inc. (NASDAQ: PAND) shares surged 133.4% to close at $59.81 on Thursday after the company announced it will be acquired by Merck for $60 per share in cash. read more